Bevacizumab, Capecitabine, Amifostine, and Preoperative Hypofractionated Accelerated Radiotherapy (HypoArc) for Rectal Cancer: A Phase II Study

References

Page 1

	Year	Citations
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny, New England Journal of Medicine	2004	10.9K
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer Rolf Sauer, Heinz Becker, Werner Hohenberger, New England Journal of Medicine	2004	6K
Cancer Statistics, 2005 Ahmedin Jemal, Thomas S. Murray, Elizabeth Ward, CA A Cancer Journal for Clinicians Epidemiology Of CancerCancer RegistrationMortality RatesUnited StatesDeath Rate	2005	5.5K
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer Jean-François Bosset, Laurence Collette, G. Calais, New England Journal of Medicine	2006	2.7K
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer Swedish Rectal Cancer Trial New England Journal of Medicine	1997	2.5K
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. David H. Gorski, Michael A. Beckett, Nora Jaskowiak, PubMed Radiation EffectImmunologyRadiation ExposureRadiation BiologyTumor Biology	1999	868
A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer J. Randolph Hecht, Edith P. Mitchell, Tarek Chidiac, Journal of Clinical Oncology	2008	851
Low Rectal Cancer: A Call for a Change of Approach in Abdominoperineal Resection Irıs D. Nagtegaal, C.J.H. van de Velde, Corrie A.M. Marijnen, Journal of Clinical Oncology	2005	569
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study Christopher G. Willett, Dan G. Duda, Emmanuelle di Tomaso, Journal of Clinical Oncology	2009	503
Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Ling Geng, Edwin F. Donnelly, Gerald McMahon, PubMed GliomaTumor ResistanceTumor BiologyRadiation MedicineAngiogenesis	2001	338

Page 1